Alcaftadine

DEA Class; OTC

Common Brand Names; Lastacaft

  •  Antihistamines, Ophthalmic
 

Topical ophthalmic H1-antagonist
Used for the prevention of ocular pruritus associated with allergic conjunctivitis
Once daily administration

Indicated for prevention of itching associated with allergic conjunctivitis

Hypersensitivity

Ocular

  • Irritation

  • Burning

  • Stinging

  • Redness

  • Pruritus

  • Eye discharge

  • Eye swelling

  • Erythema of eyelid

  • Eyelid edema

Nonocular

  • Nasopharyngitis

  • Headache

  • Influenza

  • Somnolence

To minimize eye injury and contamination of dropper tip and solution, care should be taken not to touch eyelids or surrounding areas with dropper tip of bottle; keep bottle tightly closed when not in use

Keep bottle tightly closed when not in use

Do not use for contact lens–related irritation

Remove contact lenses before instillation

Use of mycophenolate mofetil (MMF) during pregnancy is associated with an increased risk of first-trimester pregnancy loss and an increased risk of multiple congenital malformations in multiple organ systems

There are no data on presence of drug in human milk, or effects on milk production; there are limited data in the National Transplantation Pregnancy Registry on effects of mycophenolate on a breastfed child; studies in rats treated with MMF have shown mycophenolic acid (MPA) to be present in milk

Adults

1 drop/day ophthalmic solution in each eye.

Geriatric

1 drop/day ophthalmic solution in each eye.

Adolescents

1 drop/day ophthalmic solution in each eye.

Children

>= 2 years: 1 drop/day ophthalmic solution in each eye.
< 2 years: Safety and efficacy have not been established.

Infants

Safety and efficacy have not been established.

Neonates

Safety and efficacy have not been established.

Alcaftadine

ophthalmic solution

  • 0.25%

About the Author

You may also like these

0